It will be valuable to assess whether human allelic variants of ATG16L1 confer altered resistance/susceptibility to respiratory infections such as IAV and whether drug‐based manipulation of non‐canonical autophagy can increase resistance at the respiratory epithelial barrier. The gene discussed is ATG16L1; the disease is respiratory tract infectious disorder.